{
  "id": "adv_mhgap#screening_cues_44f00830",
  "content": "of the balance of benefits and harms. Antidepressant medicine alone for adults with\ndepression (moderate to severe) should only be considered when psychological\ninterventions are not available. Providers should keep in mind the possible adverse effects\nassociated with antidepressant medicines, and individual preferences.\nConditional recommendation. Low certainty of evidence.\nxxiv\nExecutive summary\nTABLE 1. (continued) Summary of recommendations\nModule and Recommendation\nrecommendation\nStrength of the recommendation and certainty of the evidence\nnumber\nDrug use disorders (DRU)\nDRU1 (update) 1.1 Adults using cannabis should be offered screening and brief intervention. Brief\nintervention should comprise at least a single session, incorporating individualized\nfeedback and advice on reducing or stopping cannabis consumption, and the offer of\nfollow-up care.\nStrong recommendation. Very low certainty of evidence.\n1.2 Adults using psychostimulants should be offered screening and brief intervention.\nBrief intervention should comprise at least a single session, incorporating individualized\nfeedback and advice on reducing or stopping psychostimulant consumption, and the offer\nof follow-up care.\nStrong recommendation. Very low certainty of evidence.\n1.3 For adults with hazardous cannabis or psychostimulant use, or with disorders due to\nuse of these substances who do not respond to brief interventions, referral for specialist\nintervention should be considered.",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "screening_cues",
      "referral",
      "management",
      "psychoeducation"
    ],
    "is_clinical": true,
    "is_advice": true
  },
  "index_text": "General — Screening Cues of the balance of benefits and harms. Antidepressant medicine alone for adults with\ndepression (moderate to severe) should only be considered when psychological\ninterventions are not available. Providers should keep in mind the possible adverse effects\nassociated with antidepressant medicines, and individual preferences.\nConditional recommendation. Low certainty of evidence.\nxxiv\nExecutive summary\nTABLE 1. (continued) Summary of recommendations\nModule and Recommendation\nrecommendation\nStrength of the recommendation and certainty of the evidence\nnumber\nDrug use disorders (DRU)\nDRU1 (update) 1.1 Adults using cannabis should be offered screening and brief intervention. Brief\nintervention should comprise at least a single session, incorporating individualized\nfeedback and advice on reducing or stopping cannabis consumption, and the offer of\nfollow-up care.\nStrong recommendation. Very low certainty of evidence.\n1.2 Adults using psychostimulants should be offered screening and brief intervention.\nBrief intervention should comprise at least a single session, incorporating individualized\nfeedback and advice on reducing or stopping psychostimulant consumption, and the offer\nof follow-up care.\nStrong recommendation. Very low certainty of evidence.\n1.3 For adults with hazardous cannabis or psychostimulant use, or with disorders due to\nuse of these substances who do not respond to brief interventions, referral for specialist\nintervention should be considered. Of the balance of benefits and harms. antidepressant medicine alone for adults with\ntrầm cảm (moderate to severe) should only be considered when psychological\ninterventions are not available."
}